ANAPTYSBIO, INC Return On Equity in % from Q3 2017 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Anaptysbio, Inc quarterly/annual Return On Equity history and growth rate from Q3 2017 to Q3 2025.
  • Anaptysbio, Inc Return On Equity for the quarter ending September 30, 2025 was -1.1K %, a 282% decline year-over-year.
  • Anaptysbio, Inc annual Return On Equity for 2024 was -273 %, a 128% decline from 2023.
  • Anaptysbio, Inc annual Return On Equity for 2023 was -119 %, a 172% decline from 2022.
  • Anaptysbio, Inc annual Return On Equity for 2022 was -43.8 %, a 186% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)

ANAPTYSBIO, INC Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -1.1K -813 -282% Jul 1, 2025 Sep 30, 2025
Q2 2025 -367 -111 -43.5% Apr 1, 2025 Jun 30, 2025
Q1 2025 -282 -121 -75% Jan 1, 2025 Mar 31, 2025
Q4 2024 -273 -153 -128% Oct 1, 2024 Dec 31, 2024
Q3 2024 -288 -206 -252% Jul 1, 2024 Sep 30, 2024
Q2 2024 -256 -190 -290% Apr 1, 2024 Jun 30, 2024
Q1 2024 -161 -109 -205% Jan 1, 2024 Mar 31, 2024
Q4 2023 -119 -75.6 -172% Oct 1, 2023 Dec 31, 2023
Q3 2023 -81.9 -39.4 -92.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -65.5 -34.1 -109% Apr 1, 2023 Jun 30, 2023
Q1 2023 -52.8 -32 -153% Jan 1, 2023 Mar 31, 2023
Q4 2022 -43.8 -28.5 -186% Oct 1, 2022 Dec 31, 2022
Q3 2022 -42.5 -44.7 -2061% Jul 1, 2022 Sep 30, 2022
Q2 2022 -31.4 -29.1 -1274% Apr 1, 2022 Jun 30, 2022
Q1 2022 -20.8 -13 -166% Jan 1, 2022 Mar 31, 2022
Q4 2021 -15.3 -10.2 -196% Oct 1, 2021 Dec 31, 2021
Q3 2021 2.17 +21.3 Jul 1, 2021 Sep 30, 2021
Q2 2021 -2.29 +17.9 +88.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -7.85 +12.1 +60.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -5.18 +17.2 +76.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -19.1 +1.54 +7.47% Jul 1, 2020 Sep 30, 2020
Q2 2020 -20.2 -3.57 -21.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 -20 -4.16 -26.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -22.3 -6.59 -41.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 -20.6 -5.77 -38.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -16.6 +1.46 +8.08% Apr 1, 2019 Jun 30, 2019
Q1 2019 -15.8 +0.81 +4.88% Jan 1, 2019 Mar 31, 2019
Q4 2018 -15.8 +3.39 +17.7% Oct 1, 2018 Dec 31, 2018
Q3 2018 -14.9 +24.5 +62.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -18.1 Apr 1, 2018 Jun 30, 2018
Q1 2018 -16.6 Jan 1, 2018 Mar 31, 2018
Q4 2017 -19.2 Oct 1, 2017 Dec 31, 2017
Q3 2017 -39.4 Jul 1, 2017 Sep 30, 2017

ANAPTYSBIO, INC Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -273 -153 -128% Jan 1, 2024 Dec 31, 2024
2023 -119 -75.6 -172% Jan 1, 2023 Dec 31, 2023
2022 -43.8 -28.5 -186% Jan 1, 2022 Dec 31, 2022
2021 -15.3 -10.2 -196% Jan 1, 2021 Dec 31, 2021
2020 -5.18 +17.2 +76.8% Jan 1, 2020 Dec 31, 2020
2019 -22.3 -6.59 -41.8% Jan 1, 2019 Dec 31, 2019
2018 -15.8 +3.39 +17.7% Jan 1, 2018 Dec 31, 2018
2017 -19.2 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.